May 30, 2024- Dr. Lili Yang receives a $6.3 million CIRM Partnering Opportunity for Translational Research Projects Award to translate a novel stem cell-engineered off-the-shelf CAR-NKT cell therapy for ovarian cancer into clinics. [Link][PDF]
May 18, 2021- Dr. Lili Yang receives a $5.9 million CIRM Partnering Opportunity for Translational Research Projects Award to translate a new stem cell-engineered off-the-shelf CAR-iNKT cell therapy for multiple myeloma into clinics. [Link][PDF]